| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
myomesin 2 | 0.570 | 0.692 | 7.0E-85 |
|
disease | 0.100 | None | 1.000 | 21 | 0 | 1990 | 2020 | ||||||||
|
membrane metalloendopeptidase | 0.407 | 0.808 | 1.5E-18 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1990 | 2017 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1990 | 2019 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.130 | None | 1.000 | 2 | 0 | 1990 | 2016 | ||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1990 | 2017 | |||||||||
|
CD19 molecule | 0.430 | 0.885 | 0.90 |
|
disease | 0.100 | None | 0.971 | 35 | 0 | 1991 | 2019 | ||||||||
|
protein tyrosine phosphatase receptor type C | 0.435 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 24 | 0 | 1991 | 2020 | ||||||||
|
keratin 20 | 0.388 | 0.846 | 9.1E-11 |
|
disease | 0.100 | None | 0.875 | 16 | 0 | 1991 | 2018 | ||||||||
|
membrane spanning 4-domains A1 | 0.411 | 0.846 | 5.1E-05 |
|
disease | 0.100 | None | 0.882 | 16 | 0 | 1991 | 2018 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.100 | None | 0.929 | 13 | 0 | 1991 | 2018 | ||||||||
|
Cerebellar degeneration-related autoantigen-3 | 0.472 | 0.808 |
|
disease | 0.100 | None | 0.917 | 12 | 0 | 1991 | 2019 | |||||||||
|
calmodulin-lysine N-methyltransferase | 0.510 | 0.808 | 1.4E-15 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 1991 | 2019 | ||||||||
|
calmodulin 1 | 0.472 | 0.808 | 0.94 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 1991 | 2019 | ||||||||
|
calmodulin 2 | 0.472 | 0.808 | 0.92 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 1991 | 2019 | ||||||||
|
calmodulin 3 | 0.485 | 0.846 | 0.93 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 1991 | 2019 | ||||||||
|
KRIT1 ankyrin repeat containing | 0.500 | 0.808 | 6.9E-04 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 1991 | 2019 | ||||||||
|
regulator of telomere elongation helicase 1 | 0.459 | 0.808 | 8.9E-10 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 1991 | 2019 | ||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 1991 | 2018 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.070 | None | 0.857 | 7 | 0 | 1991 | 2018 | |||||||||
|
CD47 molecule | 0.468 | 0.769 | 0.92 |
|
disease | 0.050 | None | 1.000 | 4 | 0 | 1991 | 2018 | ||||||||
|
CD24 molecule | 0.472 | 0.769 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1991 | 2019 | |||||||||
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
disease | 0.130 | None | 1.000 | 3 | 2 | 1991 | 2019 | |||||||||
|
complement C3d receptor 2 | 0.556 | 0.654 | 4.7E-19 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1991 | 2014 | ||||||||
|
alkaline phosphatase, intestinal | 0.563 | 0.769 | 2.5E-18 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1991 | 2015 | ||||||||
|
alkaline phosphatase, placental | 0.487 | 0.808 | 1.8E-13 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1991 | 2015 |